Stability Indicating HPLC Method for the Determination of Nicotine Hydrogen Tartrate

 

G.R. Shendarkar, P.S. Tarte*, M.H. Ghante, A.B. Roge

Nanded Pharmacy College, Shyam Nagar, Kasturba Matru Svea Bhavan, Shyam Nagar, Nanded-431605, Maharashtra, India

*Corresponding Author E-mail: pawantarte@rediffmail.com

 

ABSTRACT:

Nicotine hydrogen tartrate was subjected to different stress test conditions and solutions so obtained were further subjected to develop a stability-indicating high performance liquid chromatographic (HPLC) method. The drug was well separated from degradation products using a reversed-phase (Intersil C-18) column and a mobile phase comprising of methanol: buffer in ratio 25:75 v/v with a positive peak purity index. The detection limit and quantification limit were found to be 0.118 mg/ml and 0.354 mg/ml, respectively. The method was validated for precision, robustness, linearity and range. Results obtained after validation study, indicate that the proposed single method allowed analysis of nicotine hydrogen tartrate, in the presence of their degradation products formed under a different stress conditions.

                                                                            

KEYWORDS: Nicotine hydrogen tartrate, HPLC, Validation, Stability, Degradation.

 

 


INTRODUCTION:

Nicotine hydrogen tartrate (NHT) (Fig 1) is a pure crystalline salt of nicotine.  Chemically it is (−)-1-Methyl-2-(3-pyridyl) pyrrolidine (+)-bitartrate salt. Nicotine is a potent parasympathomimetic alkaloid, it acts as a nicotinic acetylcholine receptor agonist. In smaller doses, its acts as a stimulant in mammals, while high amounts (30–60 mg) can be fatal. 1-2

 

To date, all analytical methods described in literature for the determination of NHT involve potentiometric and spectrophotometric methods3-4. The aim of the present study was to develop an accurate, precise, specific, reproducible and stability indicating HPLC method for the estimation NHT.  The NHT was intentionally degraded by acid, base, oxide, dry heat, wet heat and UV light treatment to check the stability and to develop stability indicating assay method 5-13. The developed analytical method was validated by means of precision, robustness, linearity and range. 14

 

Fig. 1: Structure of NHT

 

MATERIALS AND METHODS:

Chemicals and reagents:

NHT was supplied by J.L. Chaturvedi College of Pharmacy, Nagpur. 

 

All the chemicals used for the study were of AR and HPLC grade. Millipore membrane filters (0.45μ) were used for filtration of mobile phase and working solutions. Double distilled and membrane filtered water was used throughout the experimental work.

 

HPLC instrumentation and conditions:

HPLC model Shimadzu SPD20-A equipped with ALC pump having variable wavelength UV- Visible detector with manual injector (20 µL). Each chromatogram was analyzed with LC Solutions software. Separations were achieved by using an Intersil C18 column (150 mm × 4.6 mm, 5 μm). The mobile phase consisted of a methanol: buffer in ratio 25:75 v/v was filtered through a 0.45 μm membrane filter to degas and pumped from the respective solvent reservoirs to the column at a flow rate of 1 ml/min. The run time was set at ten min.

 

FORCED DEGRADATION OF NICOTINE HYDROGEN TARTRATE:

Acid degradation:

Acid degradation of NHT was carried out in three different conditions.

1)     Quantity of drug equivalent to 10 mg was dissolved in 20 ml of 0.5 M HCL and resulting solution refluxed 90 min at 80°C.

2)     Quantity of drug equivalent to 10 mg was dissolved in 20 ml of 1 M HCL and resulting solution refluxed 5 h at 80°C.

3)     Quantity of drug equivalent to 10 mg was dissolved in 20 ml of 5 M HCL and resulting solution refluxed 5 h at 80°C.

 

After cooling the resulting mixtures at room temperature, solutions was neutralized with NaOH and finally diluted with diluent (methanol: water in ratio 15:85 V/V) to obtain a final concentration of 100µg/ml.

 

Base degradation:

Alkaline degradation of NHT was carried out in three different conditions.

1)     Quantity of drug equivalent to 10 mg was dissolved in 20 ml of 0.5 M NaOH and resulting solution refluxed 90 min at 80°C.

2)     Quantity of drug equivalent to 10 mg was dissolved in 20 ml of 1 M NaOH and resulting solution refluxed 5 h at 80°C.

3)     Quantity of drug equivalent to 10 mg was dissolved in 20 ml of 5 M NaOH and resulting solution refluxed 5 h at 80°C.

 

After cooling the resulting mixtures at room temperature, solutions was neutralized with HCL and finally diluted with diluent to obtain a final concentration of 100µg/ml.

 

Hydrogen peroxide degradation:

Accurately weigh quantity equivalent to 10 mg of NHT was dissolved in 20 ml of 30% hydrogen peroxide solution present in three different flasks and resulting solutions were then stored for 2 h, refluxed for 90 min and 2 h at 80°C, respectively. After cooling at room temperature, dilution was done with diluent to obtain a concentration of 100µg/ml.

 

Dry heat degradation:

The NHT was kept in oven at 60° C for 12 h, resulting sample was dissolved in diluent to obtain concentration 100 µg/ml to study dry heat degradation.

 

Photochemical degradation:

Quantity of NHT equivalent to 10 mg was transferred to 100 ml of volumetric flask and diluted to a mark with diluent. Resulting solution was then exposed to 254 nm for 24 h.

 

Water hydrolysis:

Accurately weigh quantity of NHT was dissolved in 15 ml of water and then refluxed for 4 h at 80°C, after cooling at room temperature dilution was done with diluent to obtain a concentration of 100 µg/ml.

 

Development of HPLC method:

HPLC studies were carried out on all the reaction solutions individually and on a mixture of the solutions in which decomposition was observed. The separations were achieved by using, methanol: buffer (buffer solution was prepared by dissolving 2.72 g of KH2PO4 and 0.18 g n-Heptane salt in 1000 ml of double distilled water) in a ratio 25:75 v/v as the mobile phase. It was filtered through 0.45 µ membrane filter and degassed before use. The working concentration 100 µg/ml was used for all degradation samples. The elution was carried out at the flow rate of 1ml /min. Detection was carried out at 260 nm at ambient temperature. A typical chromatogram of NHT was shown in (Fig. 2).

 

The peak area, retention time (Rt), capacity factor, theoretical plate, and peak symmetry were calculated for replicate estimation of same concentration of drug for five times. The values obtained demonstrated the suitability of the system for the analysis of the NHT. System suitability parameters fall within 2 % coefficient of variation (% RSD) during routine performance of the method. The summary of the system suitability results were showed in the (Table 1).

 


 

Table No 1: System suitability parameters of NHT

Injection

Retention time (min)

Tailing

No. of theoretical plates

Peak area

1

6.922

1.12

7930

379170

2

6.928

1.12

7908

378470

3

6.938

1.12

7851

379117

4

6.924

1.13

7926

378671

5

6.927

1.12

7939

378495

Mean

6.93

1.12

7910.80

378784.60

Std. Dev.

0.0062

0.0045

35.2803

337.1829

% RSD

0.0892

0.3986

0.4460

0.0890

 

Table No 2: Stress study of NHT

Stress conditions

Duration

(Time)

Temp.

Peak area (Standard)

Peak area*  (sample)

 

% Purity*

±SD

% RSD

0.5 M HCl

90 min

80°C

364880

354330.00

98.99

0.4636

0.4683

1 M HCl

5h

80°C

379320

373239.33

98.98

0.6995

0.7066

5 M HCl

5h

80°C

379320

387948.67

99.29

1.0517

1.0592

0.5 M NaOH

90 min

80°C

364880

389590.00

98.28

0.8771

0.8924

1 M NaOH

5h

80°C

379320

374247.33

99.34

0.7398

0.7447

5 M NaOH

5h

80°C

379320

388936.00

99.30

0.3424

0.3448

30% H2O2

2 h

-

379320

264001.67

73.50

0.8510

1.1578

30% H2O2

90 min

80°C

364880

189206.67

85.14

1.1050

1.2978

30% H2O2

2h

80°C

379320

264001.67

73.50

0.8510

1.1578

Dry heat

12 h

60°C

379320

345449.33

99.59

1.0979

1.1025

Photolytic at λ -254 nm

30h

Room temp

379320

345580

98.10

1.2590

1.2707

Water hydrolysis

4 h

80°C

379320

352689.67

98.83

0.7779

0.7871

*Results are mean of three replicates

 

 


Table No 3: Linearity study for NHT

Sr.No.

Concentration (µg/ml) () (µg/ml)

Peak  area*

1

20

84088

2

40

147763

3

60

231594

4

80

313114

5

100

389742

6

120

478277

7

140

559436

*Results are mean of three replicates

 

VALIDATION PARAMETERS:

Linearity:

Accurately weigh quantity of drug equivalent 100 mg of NHT was transferred to 100 ml of volumetric flask and diluted with diluent to a mark. (Stock solution)

 

Stock solution was father diluted to get the concentration of 20, 40, 60, 80 100, 120 and 140 µg/mL.  Equal volume of each solution was injected individually and peaks were recorded and graph was plotted as concentration verses area response of NHT.

 

Precision:

Precision of analytical method was ascertained by replicate estimation of same concentrations of drug for five times. The results are expressed as SD and % RSD of series of measurements.

 

LOQ and LOD:

LOQ and LOD value represent the sensitivity of the proposed analytical method. LOD and LOQ of the drugs were calculated using the following equations.

 

LOD = 3.3 x [σ]/S

LOQ = 10 x [σ]/S

Where σ = the standard deviation of the response and S = the slope of the calibration curve (S) (Table 4).

 

Robustness:

The robustness of the assay method was established by introducing small changes in the HPLC condition i.e. flow rate (0.8, 1 and 1.2 ml/min). Robustness of the method was studied using five replicates at a concentration level of 100 µg /ml.

 

Table No 4: Robustness study of NHT

Sr. No.

Flow rate (ml/min)

0.8

1

1.2

1

390342.00

365668.00

268491.00

2

394437.00

361602.00

270662.00

3

387396.00

363972.00

266363.00

4

390852.00

368629.00

271252.00

5

394304.00

364527.00

266946.00

Mean

391466.20

364879.60

268742.80

±S.D.

2961.6869

2567.6011

2175.7042

% RSD

0.7566

0.7037

0.8096

Results are mean of three replicates

 

RESULT AND DISCUSSION:

No stability indicating method is available in the official compendia using HPLC for analyzing NHT till now. The present proposed method was used for the complete separation of the analytes in less than 10 min and the method can be successfully applicable to perform long-term and accelerate stability studies of NHT. The representative chromatogram obtained for NHT is shown in Fig. 1. The theoretical plates were 7910 (more than 2000) and tailing was1.12 (less than 2) for the NHT peak (Table 1).  The method permits detection and quantitation of NHT in the presence of its degradation products. It was subjected to stress conditions as per ICH guidelines. The chromatograph of NHT degradation in acidic and basic condition showed no additional peak and there is no change in peak area, so it was found to be stable in acidic (Fig. 3-5) and basic (Fig. 6-8) conditions. The chromatogram of the hydrogen peroxide (30 %) degraded sample for NHT show additional peaks as follows, sample stored for 2 h show additional peaks at retention time 4.187 and 4.887 min, reflux for 90min at 80°C showed additional peaks at Rt 4.153 min and 5.507 min and reflux for 2 h at 80°C showed additional peaks at Rt 4.327, 4.733 and 6.95 min. (Fig. 9-11) Additional obtained indicating that NHT undergoes degradation under hydrogen peroxide condition. 


 

Fig. 2: Chromatogram of NHT

 

 

Fig.3:Chromatograph of NHT subjected to acid (0.5 M) degradation at 80°C for 90 min

 

Fig. 4: Chromatograph of NHT subjected to acid (1M) degradation at 80°C for 5 h

 

 

Fig.5: Chromatograph of NHT subjected to acid (5M) degradation at 80°C for 5 h

 

 

Fig.6:  Chromatograph of NHT subjected to base (0.5M) degradation at 80°C for 90min

 

Fig.7: Chromatograph of NHT subjected to base (1M) degradation at 80°C for 5 h reflux

 

Fig.8: Chromatograph of NHT subjected to  base (5M) degradation at 80°C for 5 h.

 

 

Fig.9: Chromatograph of NHT subjected to H2O2 (30%) degradation at 80°C for 90 min

 

Fig.10: Chromatograph of NHT subjected to  H2O2 (30%) degradation for 2 h

 

 

Fig.11: Chromatograph of NHT subjected to H2O2 (30%) degradation at 80°C for 2h

 

Fig.12: Chromatograph of NHT subjected to  dry heat degradation at 60 ºC for 12 h

 

 

Fig.13: Chromatograph of NHT subjected to photo degradation at 254 nm for 30 h

 

Fig.14: Chromatograph of NHT subjected to water hydrolysis at 80°C for 4 h

 


It was found to be stable under dry heat (Fig. 12) and photolytic conditions (Fig. 13). Chromatograph of water hydrolysis shows no additional peak (Fig. 14).The drug can be analyzed in the presence of different degradation products by using isocratic conditions and mobile phase containing methanol: buffer in ratio 25:75 v/v (Table 2).

 

Method is highly specific for the determination of NHR as

·        The blank solution (Mobile phase) should not show any interference at the retention time corresponding to the peak of NHT and its impurities.

·        The blank solution of peroxide degradation should not show any interference at the retention time corresponding to the peak of NHT and its impurities.

 

The method was validated for parameters like precision, linearity, LOD, LOQ, and robustness. Linearity was studied over the concentration range 20–140 µg/mL (Table 3) and the regression equation was found to be y= 4009.3x – 5886.6 with correlation coefficient of 0.9997, indicating that method is accurate. The LOQ was found to be 0. 358 µg/mL and LOD was found to be 0.118 mg/mL. The %RSD of precision (Table 1) and robustness studies (Table 4) was found to be less than 2.0%, indicating that the method is precise and robust.

 

CONCLUSION:

A specific stability indicating HPLC method was developed for the quantitative determination of NHT and it was validated with respect to various analytical parameters. Statistical data of various analytical parameters proves that method is suitable for routine analysis and long term and short term stability study of NHT with good linearity, robustness and precision.  Developed method can be used for the quantitative determination of NHT with simultaneous separation of their degraded products. The mobile phase, solvent mixture and degradation product under same condition as that of analytical conditions of NHT does not show any interference to analyte peak, peak purity is satisfactory. Thus the method is rightfully used in quality control laboratory for release of production batches and stability study.

 

REFERENCE:

1.        Neil MJO, Heckelman PE, Koch CB, Roman KJ, Kenny C M, D’Arecca MR. The Merck Index, An Encyclopedia of chemicals drugs and biological. Merck Research Laboratories, NJ, USA, 2006; p 1128.

2.        http://www.sigmaaldrich.com/catalog/product/sigma/n5260?lang=en&region=IN

3.        Chauhan SS, Lin S, Madan PL. Preparation and evaluation of nicotine hydrogen tartrate fast dissolving films for smoking cessation. Asian J Pharm 2012; 7 (3): 181-192.

4.        Willits CO, Swan Margaret L, Connelly JA, Brice BA. Spectrophotometric determination of nicotine. Anal Chem 1950; 22: 430–433.

5.        Bakshi M, Singh S. Development of validated stability-indicating assay methods-critical review. J Pharm Biomed Anal 2002; 28:1011–1040.

6.        Singh S, Bakshi M. Guidance on Conduct of Stress Tests to Determine Inherent Stability of Drugs, Pharm Tech On-Line 2000; April: 1-14.

7.        Kumarn BSP, Annapurna MM, Pavani S. Development and validation of a stability indicating RP-HPLC method for the determination of Rufinamide. J Pharm Ana 2013; 3(1): 66–70.

8.        Ngwa G. Forced Degradation as an Integral Part of HPLC Stability-Indicating Method Development. Drug Delivery Technology. June 2010, 10 (5): XX.

9.        Shah DA, Bhatt KK, Mehta RS, Baldania SL, Gandhi TR. Stability indicating RP-HPLC estimation of nebivolol hydrochloride in pharmaceutical formulations Indian J Pharm Sci 2008; 70: 591-595.

10.     Dangi M, Chaudhari D, Sinker M, Racha V, Damle M et al. Stability indicating HPTLC method for estimation of nebivolol hydrochloride and amlodipine besylate in combination. Eur asian J Anal Chem 2010; 5(2): 161-169.

11.     Sherikar O, Mehta P. Comprehensive assessment of degradation behaviour of aspirin and atorvastatin singly and in combination by using a validated RP-HPLC method. Sci Pharm 2013; 81: 195–210.

12.     ICH Q1A (R2). Stability Testing of New Drug Substances and Products. Geneva: International Conference on Harmonization; 2003. 

13.     ICH Q2 (R1). Validation of Analytical Procedures: Text and Methodology. Geneva: International Conference on Harmonization; 2005.

 

 

 

 

Received on 30.07.2014         Modified on 15.08.2014

Accepted on 20.08.2014         © AJRC All right reserved

Asian J. Research Chem. 7(9): September 2014; Page 787-794